GB0802903D0 - Treatment of diabetes - Google Patents

Treatment of diabetes

Info

Publication number
GB0802903D0
GB0802903D0 GB0802903A GB0802903A GB0802903D0 GB 0802903 D0 GB0802903 D0 GB 0802903D0 GB 0802903 A GB0802903 A GB 0802903A GB 0802903 A GB0802903 A GB 0802903A GB 0802903 D0 GB0802903 D0 GB 0802903D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0802903A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GB0802903A priority Critical patent/GB0802903D0/en
Publication of GB0802903D0 publication Critical patent/GB0802903D0/en
Priority to JP2010546398A priority patent/JP5722632B2/en
Priority to EP09712052.1A priority patent/EP2257286B1/en
Priority to US12/918,037 priority patent/US20110015226A1/en
Priority to ES09712052.1T priority patent/ES2620743T3/en
Priority to PCT/GB2009/000417 priority patent/WO2009103953A1/en
Priority to CN2009801136557A priority patent/CN102006869B/en
Priority to CA2752868A priority patent/CA2752868C/en
Priority to US13/759,173 priority patent/US20140011841A1/en
Priority to US14/974,536 priority patent/US10842784B2/en
Ceased legal-status Critical Current

Links

GB0802903A 2008-02-18 2008-02-18 Treatment of diabetes Ceased GB0802903D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB0802903A GB0802903D0 (en) 2008-02-18 2008-02-18 Treatment of diabetes
CA2752868A CA2752868C (en) 2008-02-18 2009-02-17 Treatment of energy utilization disease
ES09712052.1T ES2620743T3 (en) 2008-02-18 2009-02-17 Treatment of energy utilization disease
EP09712052.1A EP2257286B1 (en) 2008-02-18 2009-02-17 Treatment of energy utilization disease
US12/918,037 US20110015226A1 (en) 2008-02-18 2009-02-17 Treatment of Energy Utilization Disease
JP2010546398A JP5722632B2 (en) 2008-02-18 2009-02-17 Treatment of energy-related diseases
PCT/GB2009/000417 WO2009103953A1 (en) 2008-02-18 2009-02-17 Treatment of energy utilization disease
CN2009801136557A CN102006869B (en) 2008-02-18 2009-02-17 Treatment of energy utilization disease
US13/759,173 US20140011841A1 (en) 2008-02-18 2013-02-05 Treatment of energy utilization disease
US14/974,536 US10842784B2 (en) 2008-02-18 2015-12-18 Treatment of energy utilization disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0802903A GB0802903D0 (en) 2008-02-18 2008-02-18 Treatment of diabetes

Publications (1)

Publication Number Publication Date
GB0802903D0 true GB0802903D0 (en) 2008-03-26

Family

ID=39271842

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0802903A Ceased GB0802903D0 (en) 2008-02-18 2008-02-18 Treatment of diabetes

Country Status (1)

Country Link
GB (1) GB0802903D0 (en)

Similar Documents

Publication Publication Date Title
IL259475A (en) Combination therapy for the treatment of diabetes
HK1148435A1 (en) Oxadiazoanthracene compounds for the treatment of diabetes
IL208354A0 (en) Methods of treatment
ZA200902374B (en) Compositions useful for the treatment of diabetes
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
GB0818074D0 (en) Treatment of biofilms
GB0822011D0 (en) Treatment
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
IL223289A0 (en) Treatment of type 2 diabetes
GB0811992D0 (en) Treatment
IL202002A0 (en) Method of treating diabetes
GB0723100D0 (en) Treatment of HFnEF
GB0820972D0 (en) Treatment
EP2498794A4 (en) Method of treatment of type 2 diabetes
GB0805912D0 (en) Treatment
GB2460445B (en) Treatment of ringworm
GB0802903D0 (en) Treatment of diabetes
GB2465211B (en) Treatment Solution
GB0817859D0 (en) Treatment of proteostatic disease
GB0819543D0 (en) Treatment of proteostatic disease
GB0813310D0 (en) Treatment of obesity
GB0802904D0 (en) Treatment of metabolic syndrome
GB0821093D0 (en) Treatment
GB0820534D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)